Eric Adéhossi

1.0k total citations
70 papers, 685 citations indexed

About

Eric Adéhossi is a scholar working on Infectious Diseases, Public Health, Environmental and Occupational Health and Epidemiology. According to data from OpenAlex, Eric Adéhossi has authored 70 papers receiving a total of 685 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Infectious Diseases, 18 papers in Public Health, Environmental and Occupational Health and 16 papers in Epidemiology. Recurrent topics in Eric Adéhossi's work include Malaria Research and Control (13 papers), Mosquito-borne diseases and control (8 papers) and Tuberculosis Research and Epidemiology (6 papers). Eric Adéhossi is often cited by papers focused on Malaria Research and Control (13 papers), Mosquito-borne diseases and control (8 papers) and Tuberculosis Research and Epidemiology (6 papers). Eric Adéhossi collaborates with scholars based in Niger, France and United States. Eric Adéhossi's co-authors include Rebecca F. Grais, Céline Langendorf, Sheila Isanaka, Philippe Parola, Françoise Gay‐Andrieu, Ousmane Guindo, Monica McNeal, Brian D. Plikaytis, Nicole Meyer and Ali Djibo and has published in prestigious journals such as New England Journal of Medicine, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Eric Adéhossi

56 papers receiving 669 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eric Adéhossi Niger 12 269 196 141 107 100 70 685
Theresa Nkuo‐Akenji Cameroon 15 202 0.8× 317 1.6× 181 1.3× 104 1.0× 45 0.5× 38 687
Narain H. Punjabi Indonesia 16 599 2.2× 265 1.4× 154 1.1× 167 1.6× 102 1.0× 25 1.2k
Ahmad Shamsizadeh Iran 14 341 1.3× 114 0.6× 85 0.6× 246 2.3× 50 0.5× 57 644
Virginio Pietra Burkina Faso 20 283 1.1× 237 1.2× 81 0.6× 337 3.1× 128 1.3× 62 838
Anne Gallay France 13 348 1.3× 113 0.6× 76 0.5× 139 1.3× 35 0.3× 34 1.0k
D. Ashley Jamaica 13 316 1.2× 374 1.9× 34 0.2× 132 1.2× 210 2.1× 23 853
Vipin M. Vashishtha India 20 418 1.6× 120 0.6× 28 0.2× 300 2.8× 79 0.8× 70 870
David R. Shlim United States 14 278 1.0× 444 2.3× 131 0.9× 77 0.7× 132 1.3× 39 796
Dimitris A. Kafetzis Greece 19 199 0.7× 348 1.8× 115 0.8× 531 5.0× 49 0.5× 36 1.1k
Nasr El-Sayed Egypt 13 297 1.1× 69 0.4× 28 0.2× 328 3.1× 74 0.7× 17 708

Countries citing papers authored by Eric Adéhossi

Since Specialization
Citations

This map shows the geographic impact of Eric Adéhossi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric Adéhossi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric Adéhossi more than expected).

Fields of papers citing papers by Eric Adéhossi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric Adéhossi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric Adéhossi. The network helps show where Eric Adéhossi may publish in the future.

Co-authorship network of co-authors of Eric Adéhossi

This figure shows the co-authorship network connecting the top 25 collaborators of Eric Adéhossi. A scholar is included among the top collaborators of Eric Adéhossi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eric Adéhossi. Eric Adéhossi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Souleymane, Mahamadou Bassirou, Tom Decroo, Eric Adéhossi, et al.. (2025). Using linezolid as a substitute for the injectable in case of ototoxicity is safer and as effective as all-oral treatment for rifampicin-resistant TB. PubMed. 2(8). 450–458.
3.
Yacouba, Abdourahamane, et al.. (2024). Antimicrobial use in hospitalized patients: a point prevalence survey across four tertiary hospitals in Niger. JAC-Antimicrobial Resistance. 6(5). dlae175–dlae175. 2 indexed citations
5.
Souleymane, Mahamadou Bassirou, Tom Decroo, Saïdou Mamadou, et al.. (2022). Definitive outcomes in patients with rifampicin-resistant tuberculosis treated in Niger from 2012 to 2019: A retrospective cohort study. International Health. 15(3). 258–264. 2 indexed citations
6.
Sokhna, Cheikh, Souleymane Brah, Abdoulaye Djimdé, et al.. (2022). COVID-19 in Africa: What else?. New Microbes and New Infections. 47. 100982–100982. 4 indexed citations
7.
Katoto, Patrick DMC, et al.. (2021). Clinical features and predictors of mortality among hospitalized patients with COVID-19 in Niger. Conflict and Health. 15(1). 89–89. 3 indexed citations
8.
Laminou, Ibrahim Maman, et al.. (2021). Co-Infection COVID-19 et Tuberculose : à propos de deux Cas à l’Hôpital National de Zinder-Niger. Health sciences and disease. 22(2). 1 indexed citations
9.
Lagaré, Adamou, et al.. (2020). A Fatal Case of COVID-19 in an Infant with Severe Acute Malnutrition Admitted to a Paediatric Ward in Niger. SHILAP Revista de lepidopterología. 2020. 1–3. 6 indexed citations
10.
Brah, Souleymane, et al.. (2018). Particularités du Diabète du Sujet Âgé de Plus de 60 Ans au Niger. Health sciences and disease. 19. 1 indexed citations
11.
Brah, Souleymane, et al.. (2017). Cutaneous Larva migrans: 3 cases at the forehead. SHILAP Revista de lepidopterología. 8(Suppl. 1). 36–39.
12.
Brah, Souleymane, et al.. (2017). Étiologies des Hypothyroïdies de l’Adulte à l’Hôpital National de Niamey(Niger). Health sciences and disease. 19(1).
13.
Brah, Souleymane, et al.. (2016). Les Dysthyroïdies dans le Service de Médecine Interne de l’Hôpital National de Niamey – Niger. Health sciences and disease. 17(4). 1 indexed citations
14.
Brah, Souleymane, et al.. (2016). Etude de l’impact socio-économique du diabète à Niamey. 18(3). 257–264.
15.
Adamou, Harissou, et al.. (2015). Fever of Unknown Origin in Africa: The Causes Are Often Determined!. Health sciences and disease. 16(2). 11 indexed citations
16.
Brah, Souleymane, et al.. (2015). Facteurs associés à la neuropathie diabétique à l’Hôpital National de Lamordé (Niamey-Niger). Health sciences and disease. 16(4).
17.
Brah, Souleymane, et al.. (2015). Inhibiteurs de la Tyrosine Kinase dans le Traitement de la Leucémie Myéloïde Chronique : Expérience du Niger. Health sciences and disease. 16(3). 1 indexed citations
18.
Saegerman, Claude, et al.. (2014). Brucellosis in sub-Saharan Africa.. Annales de médecine vétérinaire. 158(1). 39–56. 2 indexed citations
19.
Saegerman, Claude, et al.. (2014). La brucellose en Afrique subsaharienne. Annales de médecine vétérinaire. 158. 5 indexed citations
20.
Adéhossi, Eric, Philippe Parola, & Philippe Brouqui. (2006). Febrile Broca's Aphasia: A Rare Presentation of Typhoid Fever. Journal of Travel Medicine. 10(3). 192–193. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026